Globus Medical: Nevro Acquisition & Integration Strategy Is a Key Component Influencing Its Future Growth!

Globus Medical’s recent earnings report presents a complex landscape shaped by its strategic acquisitions and ongoing efforts to streamline and integrate its expansive portfolio. The company reported second-quarter sales of $745 million, marking an 18.4% increase over the previous year. This growth was partly attributable to the recent acquisition of Nevro, which contributed $94.6 million in revenue. Despite this acquisition, the legacy Globus business managed to grow by 3.3% as reported and 4.9% when adjusted for fewer selling days.